ProCE Banner Activity

New Agents and Therapeutic Combinations for the Frontline Treatment of Peripheral T-Cell Lymphoma—Downloadable Slides

Slideset Download
Review expert perspectives on applying the latest efficacy and safety data to first-line treatment of different PTCL subtypes using both established and investigational regimens.

Released: August 28, 2019

Expiration: August 26, 2020

No longer available for credit.

Share

Faculty

Helen Hancock

Helen Hancock, NP

Clinical Trials Nurse Practitioner
T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
New York, New York

Steven M. Horwitz

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Seagen

Faculty Disclosure

Primary Author

Helen Hancock, NP

Clinical Trials Nurse Practitioner
T-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
New York, New York

Steven M. Horwitz, MD

Assistant Attending Physician, Lymphoma Service
Department of Medicine
Memorial Sloan-Kettering Cancer Center
New York, New York